Menu Back toHow-Risk-Based-Monitoring-and-eSource-Methodologies-are-Impacting-Clinical-Sites-Patients-Regulators-and-Sponsors

DIA 2015 51st Annual Meeting: Develop. Innovate. Advance.

Full conference and one-day registrants will have access to presentation PDFs through Friday, December 18, 2015 <A href="">Review Presentations </A>

How Risk-Based Monitoring and eSource Methodologies Are Impacting Clinical Sites, Patients, Regulators and Sponsors

Session Chair(s)

Jules T Mitchel, PhD, MBA

Jules T Mitchel, PhD, MBA

  • President
  • Target Health, United States
This symposium will show how risk-based monitoring and eSource methodologies are impacting the way clinical trials are being conducted and managed.
Learning Objective : Identify and assess commonalities and differences between regulatory expectations for eClinical/eSource. Assess the level of compliance of your company’s in-house or third party eClinical/eSource solutions. Identify options for addressing challenges with and leveraging opportunities offered by eSource solutions. What can Sponsors and CROs do? What can eClinical suppliers do?


Frances  Nolan, MBA

The Time Is Now for Risk-Based Monitoring

Frances Nolan, MBA

  • Independent Consultant
  • Independent Consulting, United States
Avik Kumar Pal, MBA

Overcoming Clinical Trial Data Collection Challenges with eSource Solution and Leveraging Mobile Technologies

Avik Kumar Pal, MBA

  • Chief Executive Officer
  • CliniOps, United States
Edward Stephen Seguine, MBA

Innovation by Design: Using eSource to Maximize Clinical Development Productivity and Efficiency

Edward Stephen Seguine, MBA

  • Chief Executive Officer
  • Clinical Ink, United States

Contact us

DIA Americas
800 Enterprise Road, Suite 200
Horsham, PA 19044-3595, USA
Phone: +1 215 442 6100
Fax: +1 215 442 6199

Questions related to the DIA 2015 51st Annual Meeting Program? Contact:

Ways to register

Registration override should work.